107 related articles for article (PubMed ID: 28662995)
1. Simplifying the human serum proteome for discriminating patients with bipolar disorder of other psychiatry conditions.
de Jesus JR; Galazzi RM; de Lima TB; Banzato CEM; de Almeida Lima E Silva LF; de Rosalmeida Dantas C; Gozzo FC; Arruda MAZ
Clin Biochem; 2017 Dec; 50(18):1118-1125. PubMed ID: 28662995
[TBL] [Abstract][Full Text] [Related]
2. A pilot study indicating the dysregulation of the complement and coagulation cascades in treated schizophrenia and bipolar disorder patients.
Santa Cruz EC; Zandonadi FDS; Fontes W; Sussulini A
Biochim Biophys Acta Proteins Proteom; 2021 Aug; 1869(8):140657. PubMed ID: 33839315
[TBL] [Abstract][Full Text] [Related]
3. Depleting high-abundant and enriching low-abundant proteins in human serum: An evaluation of sample preparation methods using magnetic nanoparticle, chemical depletion and immunoaffinity techniques.
de Jesus JR; da Silva Fernandes R; de Souza Pessôa G; Raimundo IM; Arruda MAZ
Talanta; 2017 Aug; 170():199-209. PubMed ID: 28501159
[TBL] [Abstract][Full Text] [Related]
4. Association between trace elements in serum from bipolar disorder and schizophrenia patients considering treatment effects.
Santa Cruz EC; Madrid KC; Arruda MAZ; Sussulini A
J Trace Elem Med Biol; 2020 May; 59():126467. PubMed ID: 31954929
[TBL] [Abstract][Full Text] [Related]
5. Metallomics-based platforms for comparing the human blood serum profiles between bipolar disorder and schizophrenia patients.
de Souza Pessôa G; de Jesus JR; Balbuena TS; Arruda MAZ
Rapid Commun Mass Spectrom; 2020 Sep; 34 Suppl 3():e8698. PubMed ID: 31837042
[TBL] [Abstract][Full Text] [Related]
6. Profiling of the Peripheral Blood Mononuclear Cell Proteome in Schizophrenia and Mood Disorders for the Discovery of Discriminatory Biomarkers: A Proof-of-Concept Study.
Coppens V; De Wachter O; Goossens J; Hendrix J; Maudsley S; Azmi A; van Gastel J; Van Saet A; Lauwers T; Morrens M
Neuropsychobiology; 2020; 79(4-5):324-334. PubMed ID: 32392557
[TBL] [Abstract][Full Text] [Related]
7. Peripheral biomarkers allow differential diagnosis between schizophrenia and bipolar disorder.
Tasic L; Larcerda ALT; Pontes JGM; da Costa TBBC; Nani JV; Martins LG; Santos LA; Nunes MFQ; Adelino MPM; Pedrini M; Cordeiro Q; Bachion de Santana F; Poppi RJ; Brietzke E; Hayashi MAF
J Psychiatr Res; 2019 Dec; 119():67-75. PubMed ID: 31568986
[TBL] [Abstract][Full Text] [Related]
8. Comparative serum proteomic analysis of a selected protein panel in individuals with schizophrenia and bipolar disorder and the impact of genetic risk burden on serum proteomic profiles.
Oraki Kohshour M; Kannaiyan NR; Falk AJ; Papiol S; Heilbronner U; Budde M; Kalman JL; Schulte EC; Rietschel M; Witt S; Forstner AJ; Heilmann-Heimbach S; Nöthen MM; Spitzer C; Malchow B; Müller T; Wiltfang J; Falkai P; Schmitt A; Rossner MJ; Nilsson P; Schulze TG
Transl Psychiatry; 2022 Nov; 12(1):471. PubMed ID: 36351892
[TBL] [Abstract][Full Text] [Related]
9. A comparison of depletion versus equalization for reducing high-abundance proteins in human serum.
Fernández C; Santos HM; Ruíz-Romero C; Blanco FJ; Capelo-Martínez JL
Electrophoresis; 2011 Nov; 32(21):2966-74. PubMed ID: 21997478
[TBL] [Abstract][Full Text] [Related]
10. Altered systemic cortisol metabolism in bipolar disorder and schizophrenia spectrum disorders.
Steen NE; Methlie P; Lorentzen S; Dieset I; Aas M; Nerhus M; Haram M; Agartz I; Melle I; Berg JP; Andreassen OA
J Psychiatr Res; 2014 May; 52():57-62. PubMed ID: 24534618
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein A-I as a candidate serum marker for the response to lithium treatment in bipolar disorder.
Sussulini A; Dihazi H; Banzato CE; Arruda MA; Stühmer W; Ehrenreich H; Jahn O; Kratzin HD
Proteomics; 2011 Jan; 11(2):261-9. PubMed ID: 21204253
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia.
Kunz M; Gama CS; Andreazza AC; Salvador M; Ceresér KM; Gomes FA; Belmonte-de-Abreu PS; Berk M; Kapczinski F
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1677-81. PubMed ID: 18657586
[TBL] [Abstract][Full Text] [Related]
13. Potential predictive plasma biomarkers for cervical cancer by 2D-DIGE proteomics and Ingenuity Pathway Analysis.
Guo X; Hao Y; Kamilijiang M; Hasimu A; Yuan J; Wu G; Reyimu H; Kadeer N; Abudula A
Tumour Biol; 2015 Mar; 36(3):1711-20. PubMed ID: 25427637
[TBL] [Abstract][Full Text] [Related]
14. Systematic evaluation of species-independent serum pre-fractionation strategies revealed cost-effective methods to reduce proteome complexity.
De A; Dutta TK; Ali MA; Behera P; Gali JM
Anal Biochem; 2019 Nov; 584():113388. PubMed ID: 31404526
[TBL] [Abstract][Full Text] [Related]
15. The difference in serum proteomes in schizophrenia and bipolar disorder.
Smirnova L; Seregin A; Boksha I; Dmitrieva E; Simutkin G; Kornetova E; Savushkina O; Letova A; Bokhan N; Ivanova S; Zgoda V
BMC Genomics; 2019 Jul; 20(Suppl 7):535. PubMed ID: 31291891
[TBL] [Abstract][Full Text] [Related]
16. Metallomics studies of human blood serum from treated bipolar disorder patients.
Sussulini A; Kratzin H; Jahn O; Banzato CE; Arruda MA; Becker JS
Anal Chem; 2010 Jul; 82(13):5859-64. PubMed ID: 20536186
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression.
Behan AT; Byrne C; Dunn MJ; Cagney G; Cotter DR
Mol Psychiatry; 2009 Jun; 14(6):601-13. PubMed ID: 18268500
[TBL] [Abstract][Full Text] [Related]
18. Specific alterations in plasma proteins during depressed, manic, and euthymic states of bipolar disorder.
Song YR; Wu B; Yang YT; Chen J; Zhang LJ; Zhang ZW; Shi HY; Huang CL; Pan JX; Xie P
Braz J Med Biol Res; 2015 Nov; 48(11):973-82. PubMed ID: 26375446
[TBL] [Abstract][Full Text] [Related]
19. Common and distinct structural features of schizophrenia and bipolar disorder: The European Network on Psychosis, Affective disorders and Cognitive Trajectory (ENPACT) study.
Maggioni E; Crespo-Facorro B; Nenadic I; Benedetti F; Gaser C; Sauer H; Roiz-Santiañez R; Poletti S; Marinelli V; Bellani M; Perlini C; Ruggeri M; Altamura AC; Diwadkar VA; Brambilla P;
PLoS One; 2017; 12(11):e0188000. PubMed ID: 29136642
[TBL] [Abstract][Full Text] [Related]
20. Search for plasma biomarkers in drug-free patients with bipolar disorder and schizophrenia using metabolome analysis.
Kageyama Y; Kasahara T; Morishita H; Mataga N; Deguchi Y; Tani M; Kuroda K; Hattori K; Yoshida S; Inoue K; Kato T
Psychiatry Clin Neurosci; 2017 Feb; 71(2):115-123. PubMed ID: 27676126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
